The hypermethylation and mRNA downregulation noted in the CMT tissue is however concurrent with previous studies where EPAS1 has been shown to be hypermethylated in its promotor with downregulated mRNA expression in non-small cell lung cancer [52] and colon cancer [47]. Here, EPAS1 is linked to non-small cell lung carcinoma.